Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Analysis

Altice USA Faces Critical Challenges in Competitive Telecom Market

Robert Sasse by Robert Sasse
September 14, 2025
in Analysis, Telecommunications, Turnaround
0
Altice usa Stock
0
SHARES
146
VIEWS
Share on FacebookShare on Twitter

The American telecommunications provider Altice USA finds itself navigating a difficult period of sustained decline. In stark contrast to the broader industry’s expansion, the company is grappling with persistent revenue decreases and a significant erosion of investor confidence. The critical question remains whether this troubled telecom operator can execute a successful turnaround.

Subscriber Erosion and Market Pressures

A fundamental challenge for Altice USA is the continuous loss of its core broadband customers. The company reported a net decline of 35,000 broadband subscribers in the second quarter of 2025, despite showing some minor quarterly improvements. Operating in a highly saturated market with fierce competition, Altice USA appears to lack the competitive edge necessary to retain its existing customer base and attract new users.

Wall Street’s Cautious Stance

Market experts maintain a guarded outlook. While six covering banks currently have a “Hold” rating on the equity, the underlying data is far from reassuring. The average price target of $2.88 implies a potential upside exceeding 20 percent; however, some forecasts project the stock could fall to just $2.28 by September. This skepticism is well-founded: revenue has contracted by a cumulative 12 percent over the past three years, and analysts anticipate a further annual shrinkage of 2.2 percent over the next three years.

Should investors sell immediately? Or is it worth buying Altice usa?

Significant Underperformance Against Sector Peers

The company’s struggles are magnified when compared to the wider sector. The telecommunications industry continues to grow at an average annual rate of 2.8 percent. Altice USA’s pronounced underperformance is reflected in its low price-to-sales ratio, indicating that investors remain doubtful about its ability to return to a growth trajectory without fundamental operational changes.

Recent efforts to address its financial position, including securing a multi-billion dollar asset-backed loan in July, demonstrate a push for stability. Nevertheless, this financial maneuvering does not resolve the core operational issues. Until the management team presents a convincing strategy to halt the revenue decline, the company’s shares are likely to remain under substantial pressure.

Ad

Altice usa Stock: Buy or Sell?! New Altice usa Analysis from February 7 delivers the answer:

The latest Altice usa figures speak for themselves: Urgent action needed for Altice usa investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from February 7.

Altice usa: Buy or sell? Read more here...

Tags: Altice usa
Robert Sasse

Robert Sasse

About Dr. Robert Sasse Accomplished economist, entrepreneur, and profound expert in financial markets. Dr. Robert Sasse holds a doctorate in economics and combines academic rigor with practical entrepreneurial experience. His deep expertise in economic relationships and unwavering conviction for a free-market liberal economic order drives his mission to provide investors with well-founded knowledge and guidance.
Areas of Expertise:
  • Economic Theory and Practice
  • Free-Market Economics
  • Entrepreneurship and Business Strategy
  • Investment Philosophy
Dr. Sasse's unique combination of academic knowledge and real-world business experience enables him to provide investors with comprehensive insights that bridge theory and practice.

Related Posts

CrossFirst Bankshares Stock
Analysis

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Myers Industries Stock
Analysis

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
Riley Exploration Permian Stock
Analysis

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

February 7, 2026
Next Post
CRA Stock

CRA International Gains Momentum with Strategic Hires and Upgraded Outlook

Capricor Therapeutics Stock

Capricor Therapeutics: A Study in Contrasting Market Sentiment

DouYu International Holdings Stock

DouYu's Profit Turnaround Fails to Impress Skeptical Market

Recommended

Super Micro Computer Stock

Super Micro Stock Surges Amid AI Infrastructure Boom

4 months ago
Adobe Stock

Adobe’s AI Ambitions Face Investor Skepticism

4 months ago
IBM Stock

Strong IBM Earnings Fail to Impress Market as Key Segment Shows Weakness

4 months ago
Inozyme Pharma Inc Stock

Inozyme Pharma Acquisition Finalized: Strategic Focus Shifts to Clinical Development

5 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Myers Industries Set to Report Full-Year and Q4 2025 Results

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

Riley Exploration Permian Bolsters Board with Industry Veteran Amid Shareholder Activity

Great Lakes Dredge & Dock: A Cash Flow Inflection Point Approaches

Investors Await March Report for Boston Omaha’s Strategic Direction

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

Trending

Orthofix Medical Stock
Earnings

Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio

by Rodolfo Hanigan
February 7, 2026
0

Investor attention turns to Orthofix Medical as the company bolsters the clinical support for its biologics business...

CrossFirst Bankshares Stock

A New Chapter for First Busey as CrossFirst Merger Finalizes

February 7, 2026
Golden Entertainment Stock

Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

February 7, 2026
Myers Industries Stock

Myers Industries Set to Report Full-Year and Q4 2025 Results

February 7, 2026
OneSpan Stock

OneSpan Strengthens Mobile Security Arsenal with Strategic Acquisition

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Orthofix Medical Strengthens Scientific Foundation for Biologics Portfolio
  • A New Chapter for First Busey as CrossFirst Merger Finalizes
  • Golden Entertainment to Exit Public Markets in Strategic Privatization Deal

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com